METASTATIC CANCER OF THE PROSTATE - HIGH-DOSE DIETHYLSTILBESTROL AND ESCAPE PHENOMENON

被引：0
|
作者：
CHAOUAT, D [1 ]
COURT, B [1 ]
机构：
[1] INST GUSTAVE ROUSSY,SERV UROL,F-94805 VILLEJUIF,FRANCE
来源：
REVUE DU RHUMATISME | 1994年 / 61卷 / 04期
关键词：
PROSTATE; METASTASIS; DIETHYLSTILBESTROL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [31] Immunotherapy for metastatic prostate cancer
    Drake, Charles G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (04) : 438 - 444
  • [32] A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement
    Matsubara, H
    Makimoto, A
    Higa, T
    Kawamoto, H
    Sakiyama, S
    Hosono, A
    Takayama, J
    Takaue, Y
    Murayama, S
    Sumi, M
    Kaneko, A
    Ohira, M
    BONE MARROW TRANSPLANTATION, 2005, 35 (08) : 763 - 766
  • [33] A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement
    H Matsubara
    A Makimoto
    T Higa
    H Kawamoto
    S Sakiyama
    A Hosono
    J Takayama
    Y Takaue
    S Murayama
    M Sumi
    A Kaneko
    M Ohira
    Bone Marrow Transplantation, 2005, 35 : 763 - 766
  • [34] Neutrophils are mediators of metastatic prostate cancer progression in bone
    Diane L. Costanzo-Garvey
    Tyler Keeley
    Adam J. Case
    Gabrielle F. Watson
    Massar Alsamraae
    Yangsheng Yu
    Kaihong Su
    Cortney E. Heim
    Tammy Kielian
    Colm Morrissey
    Jeremy S. Frieling
    Leah M. Cook
    Cancer Immunology, Immunotherapy, 2020, 69 : 1113 - 1130
  • [35] Neutrophils are mediators of metastatic prostate cancer progression in bone
    Costanzo-Garvey, Diane L.
    Keeley, Tyler
    Case, Adam J.
    Watson, Gabrielle F.
    Alsamraae, Massar
    Yu, Yangsheng
    Su, Kaihong
    Heim, Cortney E.
    Kielian, Tammy
    Morrissey, Colm
    Frieling, Jeremy S.
    Cook, Leah M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (06) : 1113 - 1130
  • [36] Localized or metastatic prostate cancer: a review of modern treatment
    Deniaud-Alexandre, E
    Mounier, N
    Pontvert, D
    Cosset, JM
    BULLETIN DU CANCER, 1998, : 40 - 50
  • [37] Management of high risk metastatic prostate cancer: The case for novel therapies
    Brand, Timothy C.
    Tolchert, Anthony W.
    JOURNAL OF UROLOGY, 2006, 176 (06): : S76 - S80
  • [38] Prognostic value of PSA nadir ≤4 ng/mL within 4 months of high-dose radiotherapy for locally advanced prostate cancer
    Nickers, Philippe
    Albert, Adelin
    Waltregny, David
    Deneufbourg, Jean-Marie
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01): : 73 - 77
  • [39] Can high-dose interleukin-2 be replaced with lower-dose, outpatient regimens for metastatic renal cell carcinoma?
    Wood, CG
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (05): : 218 - 219
  • [40] High-dose vitamin D metabolite delivery inhibits breast cancer metastasis
    Liu, Jiaye
    Shen, Junyi
    Mu, Chunyang
    Liu, Yang
    He, Dongsheng
    Luo, Han
    Wu, Wenshuang
    Zheng, Xun
    Liu, Yi
    Chen, Sunrui
    Pan, Qiuwei
    Hu, Yiguo
    Ni, Yinyun
    Wang, Yang
    Liu, Yong
    Li, Zhihui
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2022, 7 (01)
12345